期刊文献+

ELISA法测定血清芬太尼浓度的价值

Value of ELISA in determination of serum fentanyl concentration
原文传递
导出
摘要 目的探讨ELISA法测定幼儿血清芬太尼浓度的价值。方法用芬太尼试剂盒拟合标准曲线,测定其检测限、精密度、回收率和交叉反应率,并检测支气管异物取出术患儿手术过程中含芬太尼血清样本90份。结果芬太尼浓度在0.03-0.48μg/L时线性良好(r2=0.994),检测限为0.03μg/L,日内和日间相对标准偏差的均值分别为9.3%和12.7%,回收率为80.0%-115.3%,与麻醉常用药物的交叉反应率低。样本芬太尼血清浓度为(0.64±0.05)μg/L。结论 ELISA法测定血清芬太尼浓度简便、快速、费用少。 Objective To investigate the value of ELISA in determination of serum fentanyl concentration in children. Methods A standard curve was established and the limit of detection, precision, recovery rate and cross-reaction rate were tested using fentanyl ELISA kits, by which serum fentanyl concentration was detected in 90 children undergoing fentanyl anesthesia for the extraction of bronchial foreign bodies. Results The linearity of the standard curve was preferable when the range of fentanyl concentration was 0. 03μg/L to 0. 48μg/L (r2=0. 994). The limit of detection was 0.03μg/L. The mean intra- and inter-assay relative standard deviations were 9.3% and 12. 7%, respectively. The range of recovery rate was from 80. 0% to 115.3%. The cross-reaction rate between fentanyl antibody and other commonly used anesthetics was lower. Serum concentration of fentanyl in 90 children was (0. 64±0. 05) μg/L. Conclusion Determination of serum fentanyl concentration by ELSIA is convenient,rapid and cheap.
出处 《江苏医药》 CAS 北大核心 2013年第20期2376-2378,共3页 Jiangsu Medical Journal
基金 南京医科大学科技发展基金(09NJMUM039)
关键词 药物监测 芬太尼 酶联免疫吸附试验 Drug monitoring~ Fentanyl ~ Enzyme-linked immunosorbent assay
  • 相关文献

参考文献5

二级参考文献30

  • 1Fraga JC, Pires AF,Komlos M, et al. Bronchoscopic removal of foreign body from airway through tracheotomy ortracheostomy[J]. Pediatr(Rio J), 2003,79(4) : 369-372.
  • 2Tomaske M, Gerber A, Weiss M, et al. Anesthesia and periinterventional morbidity of rigid bronehoseopy for tracheobronchial foreign body diagnosis and removal[JJ. Paediatr Anaesth, 2006,16 (2) : 123-129.
  • 3Divisi D, Di Tommaso S, Garramone M, et al. Foreign bodies aspirated in children: role of bronchoscopy[J].Thorac Cardiovasc Surg, 2007,55 (4) : 249-252.
  • 4Shorvon SD, Dreifuss F, Fish D, et al. The treatment of epilepsy [M]. ed 3. London: Blackwell Science, 1996. 138~425.
  • 5Guberman A, Bruni J. Essentials of clinical epilepsy[M]. ed 2.Boston: Butterworth - Heinemann, 1999. 207.
  • 6Mattson RH, Cramer JA. Collins JF. Prognosis for total control of complex partial and secondarily generalized tonic clonic seizures [J]. Neurology, 1996,47:68~76.
  • 7Brodie MJ, Dichter MA. Antiepileptic drugs[J]. N Engl J Med, 1996,334:168~ 175.
  • 8Devinsky O. Patients with refractory seizures[J]. N Engl J Med, 1999,340: 1565~1570.
  • 9Perucca E. The clinical pharmacokinetics of the new antiepileptic drugs[J]. Epilepsia, 1999,40:S 7~13.
  • 10Perucca E. Pharmacokinetic profile of topiramate in comparison with other new antiepileptic drugs[J]. Epilepsia, 1996,37: S 8~13.

共引文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部